Xiaojin Wu, Prof.
The First Affiliated Hospital of Soochow University
5
3
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Depei Wu, Prof.
The First Affiliated Hospital of Soochow University
Shared therapeutic areas:
Worked with same sponsors:
Susan Prockop, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Mitchell Cairo, MD
New York Medical College
Shared therapeutic areas:
Jacques Galipeau, MD
University of Wisconsin, Madison
Shared therapeutic areas:
Helen E Heslop, MD
Baylor College of Medicine
Shared therapeutic areas:
Lung-Ji Chang, PhD
Shenzhen Geno-Immune Medical Institute
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Meral Boşnak Güçlü, PhD
Gazi University
Shared therapeutic areas:
Ryotaro Nakamura
City of Hope Medical Center
Shared therapeutic areas:
Sung-Han Kim, MD
Asan Medical Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China
All 5 trials loaded